4.4 Review

All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis

Journal

SYSTEMATIC REVIEWS
Volume 11, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13643-022-02146-5

Keywords

Bleeding; Direct oral anticoagulants; Mortality; Anticoagulation

Funding

  1. Canadian Institutes of Health Research
  2. Tier 2 Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease [CDT-142654]

Ask authors/readers for more resources

This systematic review and meta-analysis aims to assess the 30-day all-cause mortality after major GI bleeding among patients receiving DOACs. The study will systematically search relevant literature, evaluate and extract data from selected studies, and pool the results through meta-analysis. The findings of this study will provide estimates of mortality after major bleeding events to support shared decision making about anticoagulation management for clinicians and patients.
Background:Gastrointestinal (GI) bleeding represents the single most frequent site of anticoagulant-related bleeding. Adverse outcomes after major GI bleeding including mortality are not well characterized and, as a result, may be underappreciated in clinical practice. We aim to conduct a systematic review and meta-analysis of the risk for 30-day all-cause mortality after major GI bleeding among patients receiving DOACs. Methods:Electronic databases including MEDLINE, EMBASE, and Cochrane CENTRAL will be systematically searched to identify randomized controlled trials and prospective and retrospective cohort studies reporting 30-day all-cause mortality in adults with DOAC-related major GI bleeding. At least two investigators will independently perform study selection, risk of bias assessment, and data extraction. The proportion of deaths following a major GI event relative to the number of major GI bleeding events will be calculated for each individual study, and results across studies will be pooled using random-effects meta-analysis. We will assess risk of bias using criteria proposed by the GRADE group for prognostic studies. Discussion:The findings of this systematic review and meta-analysis will provide clinicians and patients with estimates of mortality after the most common major bleeding event to support shared decision making about anticoagulation management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Medicine, General & Internal

Fostering the intersection between primary care and hospital: hints from a survey and the PRIME (PRIMary care-hospital Embedding) project

Marco Montagna, Nuccia Morici, Tobias Tritschler, Patrizia Rovere Querini

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Review Pediatrics

The Impact of Patient and Family Engagement in Child Health Research: A Scoping Review

Shelley M. Vanderhout, Manav Bhalla, Alicia Van, Dean A. Fergusson, Beth K. Potter, Aliza Karoly, Valentina Ly, Colin Macarthur

Summary: This scoping review examined the impacts of patient and family engagement on child health research. It found that engagement has significant effects on the research process, research teams, and patient and family partners. However, the evaluation of these impacts is rare, highlighting the need for systematic and standardized evaluation.

JOURNAL OF PEDIATRICS (2023)

Meeting Abstract Hematology

Clinical Benefits, Harms, and Cost-Effectiveness of Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Decision Analytic Modelling Study

Faizan Khan, Doug Coyle, Kednapa Thavorn, Sasha van Katwyk, Tobias Tritschler, Brian Hutton, Gregoire Le Gal, Marc A. Rodger, Dean Fergusson

BLOOD (2022)

Article Hematology

Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials

Carla Schenker, Odile Stalder, Marie Mean, Tobias Tritschler, Marc Righini, Nicolas Rodondi, Drahomir Aujesky

Summary: The underrepresentation of older patients with VTE in clinical anticoagulation trials is a problem. This study examined the exclusion of elderly patients and compared bleeding risks between excluded and enrolled patients. The study found that about one-third of older patients would be excluded from participation in these trials, and the bleeding risk increases with the number of exclusion criteria.

THROMBOSIS AND HAEMOSTASIS (2023)

Article Medicine, General & Internal

Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism

Faizan Khan, Kednapa Thavorn, Doug Coyle, Sasha van Katwyk, Tobias Tritschler, Brian Hutton, Gregoire Le Gal, Marc Rodger, Dean Fergusson

Summary: This study aims to assess the differences in clinical benefits, harms, and costs of stopping versus continuing anticoagulant therapy indefinitely for a first unprovoked venous thromboembolism (VTE). A probabilistic Markov model will be developed to estimate life-years, quality-adjusted life-years, costs, and incremental cost-effectiveness ratios. The results will be disseminated through conferences and a peer-reviewed journal.

BMJ OPEN (2023)

Article Medicine, General & Internal

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization

Tracy Y. Wang, Abdus S. Wahed, Alison Morris, Lisa Baumann Kreuziger, John G. Quigley, Gervasio A. Lamas, Alexandra J. Weissman, Jose Lopez-Sendon, M. Margaret Knudson, Deborah M. Siegal, Raj S. Kasthuri, Andrew J. Alexander, Lana Wahid, Bassel Atassi, Peter J. Miller, Janice W. Lawson, Bela Patel, Jerry A. Krishnan, Nancy L. Shapiro, Deborah E. Martin, Andrei L. Kindzelski, Eric S. Leifer, Jungnam Joo, Lingyun Lyu, Annie Pennella, Brendan M. Everett, Mark W. Geraci, Kevin J. Anstrom, Thomas L. Ortel

Summary: This study aimed to determine whether anticoagulation is effective in reducing death and thromboembolic complications among patients discharged after COVID-19 hospitalization. The study was terminated early due to a lower-than-expected event rate and declining COVID-19 hospitalizations, leading to inconclusive results.

ANNALS OF INTERNAL MEDICINE (2023)

Review Multidisciplinary Sciences

Impact of coaching on physician wellness: A systematic review

Sylvain Boet, Cole Etherington, Pierre-Marc Dion, Chloe Desjardins, Manvinder Kaur, Valentina Ly, Manon Denis-LeBlanc, Cecile Andreas, Abi Sriharan

Summary: Physician wellness is crucial for patient safety and quality care. This review examines the impact of coaching by trained coaches on physician well-being, distress, and burnout. The evidence suggests that coaching for physicians can improve their well-being and reduce distress and burnout.

PLOS ONE (2023)

Article Hematology

Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism

Jan O. Gaugler, Marc Righini, Helia Robert-Ebadi, Olivier Sanchez, Pierre-Marie Roy, Franck Verschuren, Sebastien Miranda, Aurelien Delluc, Gregoire Le Gal, Tobias Tritschler

Summary: This study evaluated the association between obesity and body mass index (BMI) with confirmed pulmonary embolism (PE) in patients with suspected PE and assessed the efficiency and safety of the age-adjusted D-dimer strategy in obese patients. The results showed that BMI and obesity were not associated with confirmed PE. The use of the age-adjusted D-dimer strategy increased the proportion of obese patients in whom PE was considered ruled out without imaging.

THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study

Kristina Vrotniakaite-Bajerciene, Tobias Tritschler, Katarzyna Aleksandra Jalowiec, Helen Broughton, Fabienne Schmidli, Jenny Sarah Schneider, Alan Haynes, Alicia Rovo, Johanna Anna Kremer Hovinga, Drahomir Aujesky, Anne Angelillo-Scherrer

Summary: This study aimed to investigate the adherence to thrombophilia testing guidelines, its therapeutic impact, and identify the patients' clinical characteristics mostly associated with treatment decisions. The findings showed poor adherence to the guidelines and no impact on treatment decisions. Therefore, refinement of selection criteria is needed to increase the therapeutic impact of thrombophilia testing.

THROMBOSIS RESEARCH (2023)

Article Anesthesiology

Small-volume tubes to reduce anemia and transfusion (STRATUS): a pilot study

Deborah M. Siegal, Emilie P. Belley-Cote, Shun Fu Lee, Tara Robertson, Stephen Hill, Pamela Benoit, Brandi Meeks, Julian Owen, Tanya Roglich, Elena Zotova, Stuart J. Connolly

Summary: The study aimed to assess the feasibility of using small-volume tubes for blood sampling to reduce transfusion in intensive care unit patients. The results showed that the implementation of small-volume tubes was feasible and did not increase the frequency of inadequate samples. These findings provide valuable insights for further research on the potential of small-volume tubes in reducing transfusion.

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2023)

Article Cardiac & Cardiovascular Systems

The effect of antithrombotic treatment on mortality in patients with acute infection: A meta-analysis of randomized clinical trials

Gianluca Gazzaniga, Giovanni Amedeo Tavecchia, Francesca Bravi, Francesca Scavelli, Giovanna Travi, Gianluca Campo, Christophe Vandenbriele, Tobias Tritschler, Jonathan A. C. Sterne, Srinivas Murthy, Nuccia Morici

Summary: This meta-analysis examined the impact of antithrombotic treatment on survival of patients with acute infectious diseases. The analysis of 18 randomized controlled trials involving 16,588 patients showed that the use of antithrombotic agents was not associated with all-cause mortality in patients with infectious disease other than COVID-19.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Review Hematology

Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review

Carla Schenker, Caterina E. Marx, Noemie Kraaijpoel, Gregoire Le Gal, Deborah M. Siegal, Frederikus A. Klok, Drahomir Aujesky, Tobias Tritschler

Summary: This study aimed to summarize definitions of fatal bleeding and describe the range of case-fatality rates of major bleeding in studies evaluating anticoagulation for venous thromboembolism (VTE). The lack of a standardized definition for fatal bleeding may lead to inaccurate estimates of the risk of fatal bleeding.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Review Hematology

Case-fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta-analysis

Tobias Tritschler, Anuj Patel, Noemie Kraaijpoel, Deepak L. Bhatt, Giuseppe De Luca, Pietro Di Santo, Fausto Feres, Ricardo A. Costa, Benjamin Hibbert, Takaaki Isshiki, Gregoire Le Gal, Lana A. Castellucci

Summary: The assessment of case-fatality rate (CFR) of major bleeding in patients receiving dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is important for understanding the risks and benefits of different durations of DAPT. This study found that the CFR of major bleeding was higher in the first 12 months of DAPT compared to long-term DAPT.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

No Data Available